Valuation
- Market cap
- 258,000
- Revenue TTM
- $0
- Net income TTM
- $-1,900,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.33
Trading
- Volume
- 2,100
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- 122,695,000
- Stochastic %K
- —
- Beta
- 0.63
- Analysts
- —
- Price target
- $3.00
Company profile
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld...
Show more
IR-Med Inc., a medical device company, engages in the development of non-invasive devices for various medical indications. The company's development products pipeline consists of PressureSafe, a handheld skin-agnostic optical monitoring device that supports early detection of pressure injuries to the skin and underlying tissue primarily caused by prolonged pressure associated with bed confinement; DiaSafe, a handheld optical monitoring device, which supports early detection of diabetic foot ulcers in lower limb skin and underlying tissue caused by prolonged pressure on the sole of diabetic patients; and Nobiotics, an otoscope to support physicians with an immediate indication as to whether mid-ear, a common malady in children. IR-Med Inc. is headquartered in Rosh Pinna, Israel.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 972 4 655 5054
- Website
- https://www.ir-medical.com
- Address
- ZHR Industrial Zone, 20 Yahalom Street PO Box 143, Rosh Pinna, Israel
Latest news
No headlines yet.